Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1930 of 6351
-
Could a cancer drug slow bile duct tumors?
Disease control Recruiting nowBackground: Cholangiocarcinoma (CCA) is an aggressive cancer of the bile ducts. People with CCA have few treatment options and poor survival. Researchers want to see if a new drug can stop or slow CCA growth. Objective: To find the safest and most effective dose of tivozanib t…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
5-Drug cocktail takes on tough cancers in new trial
Disease control Recruiting nowThe purpose of this Phase I/II study is to determine the safety and effectiveness of up to 5 study drugs used together for the treatment of solid tumor cancers. The drugs are hydroxychloroquine, metformin, sirolimus, dasatinib and nelfinavir and are given orally.
Phase 1/2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Spit test could spot oral cancer before it spreads
Diagnosis Recruiting nowHead and neck squamous cell carcinoma (HNSCC) are malignant tumors originating from the epithelial mucosa of the upper aerodigestive tract. The oral cavity is the most frequent location of HNSCC (oral squamous cell carcinoma: OSCC). Tobacco use and alcohol consumption are the gre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New drug could help people with short bowel syndrome ditch IV nutrition
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(sonefpeglutide) in adult subjects with SBS-associated intestinal failure (SBS-IF).
Phase 2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Spinal zap hope: electrical stimulation may help kids with spinal injury walk
Symptom relief Recruiting nowAim 1: Determine the safety and feasibility of administration of TSCS to children in a clinical setting. Participants will be randomly assigned to experimental (TSCS) or control (sham stimulation) groups. Both groups will receive eight-weeks of individualized gait training. We wi…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Smart shoes aim to stop diabetic foot ulcers in their tracks
Disease control CompletedPreventing foot ulcers in people with diabetes can reduce costs and increase quality of life. Despite availability of various interventions to prevent foot ulcers, recurrence rates remain high. We hypothesise that a multimodal approach incorporating a variety of orthotic interven…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a simple blood test guide MS treatment? new study tests ofatumumab switch
Disease control OngoingThis study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) l…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to outsmart resistant cancers
Disease control OngoingThis is a multi-centre Phase I dose finding and proof-of-concept study of the combination of ASTX660 together with Pembrolizumab with expansion cohorts testing preliminary efficacy in immune-refractory cancers, triple negative breast cancer (TNBC), cervical cancer, and glioblasto…
Phase 1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope: preventing diabetes in childhood cancer survivors
Prevention OngoingThis is a first-in survivor, single-arm pilot study with the goal of establishing evidence of feasibility and safety of a combined pharmacologic (metformin) and lifestyle intervention (using an existing digital platform) to prevent diabetes in prediabetic adult survivors of child…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Heart surgery anesthesia showdown: can ketamine shield kidneys better than propofol?
Disease control OngoingThe purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New device aims to fix leaky heart valve without open surgery
Disease control Recruiting nowThe objective of this early feasibility study is to gain early clinical insight into Trisol system safety and performance to treat patients with moderate or greater tricuspid regurgitation (TR).
Sponsor: Trisol Medical • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common steroid save lives in sepsis? new trial investigates
Disease control CompletedThe purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.
Phase 1/2 • Sponsor: CHA University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common diabetes drug ease leg pain for millions?
Symptom relief Recruiting nowPeripheral arterial disease (PAD) affects over 20% of aged adults and is very common among Veterans due significant tobacco use. PAD is due to the progressive blockage of peripheral arteries, predominantly to the legs, and results in intermittent claudication (IC) or recurrent mu…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare blood cancers: fedratinib shows promise in early trial
Disease control CompletedThe purpose of the study is to evaluate the effectiveness, safety, and tolerability of a study drug called fedratinib in participants with myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) and chronic neutrophilic leukemia (CNL).
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill shows promise in quieting MS brain lesions
Disease control OngoingThis is a study evaluating the effect of fenebrutinib on brain magnetic resonance imaging (MRI) in participants with RMS. The safety and pharmacokinetics of fenebrutinib will also be evaluated. Participants will be randomized to receive either fenebrutinib or placebo. This study …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New Drug-Free program shows promise for easing anxiety in severe mental illness
Symptom relief CompletedFew alternatives to addictive medical treatment exists for persons with severe mental health problems (SMHP) and anxiety, often connected to high risk of suicide. Access to effective interventions that depart in individuals' needs to cope with anxiety in everyday life is crucial …
Sponsor: Lund University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Slovenian study aims to predict who benefits from melanoma immunotherapy
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the efficacy of immunotherapy in the first-line treatment of metastatic melanoma in Slovenia and to investigate the association between PD-L1 expression and treatment response. The study aims to determine the relationship between exosomal …
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Telehealth therapy aims to curb suicide in disabled adults
Symptom relief CompletedThe purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Gut shield: probiotic and amino acid combo may stop cancer drug side effect
Prevention Recruiting nowThis open-label randomized clinical trial aims to evaluate the glutamine plus Lactobacillus reuteri supplementation effect in a standard-of-care diet in EGFR mutant patients with advanced non-small cell lung cancer (NSCLC) under tyrosine kinase inhibitors (TKIs) therapy. The mai…
Phase 3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
Spinal zaps and exercise may boost walking after injury
Symptom relief OngoingFor many people with spinal cord injury (SCI), the goal of walking is a high priority. There are many approaches available to restore walking function after SCI; however, these approaches often involve extensive rehabilitation training and access to facilities, qualified staff, a…
Sponsor: Shepherd Center, Atlanta GA • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC